SCHEMBL212006

SCHEMBL212006

C[CH]c1ccc(F)c(F)c1[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
TDP1 Q9NUW8 2/20 0.35
HIF1A Q16665 1/20 0.35
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
VCAM1 P19320 1/20 0.33
ATM Q13315 1/20 0.32
TSHR P16473 2/20 0.32
ARNT P27540 1/20 0.32
EPAS1 Q99814 1/20 0.32
MAPT P10636 2/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
VCP P55072 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1592576 0.83 ERN1 (0.37) ALDH1A1TDP1HIF1AVCAM1ATM
SCHEMBL31413408 0.83 ERN1 (0.37) ALDH1A1TDP1HIF1AVCAM1ATM
SCHEMBL27152155 0.81 ALDH1A1 (0.35) ALDH1A1TDP1HIF1AMEN1KMT2A
SCHEMBL214270 0.78 ALDH1A1 (0.44) ALDH1A1TDP1MEN1KMT2ATSHR
SCHEMBL1340438 0.78 ALDH1A1 (0.43) ALDH1A1TDP1HIF1AVCAM1ATM
SCHEMBL29860351 0.78 ALDH1A1 (0.43) ALDH1A1TDP1HIF1AVCAM1ATM
SCHEMBL73931 0.72 TDP1 (0.50) ALDH1A1TDP1HIF1AMEN1KMT2A
SCHEMBL29860564 0.72 MAPT (0.40) ALDH1A1TDP1HIF1AMEN1KMT2A
SCHEMBL212007 0.72 ALDH1A1 (0.36) ALDH1A1TDP1HIF1AVCAM1ATM
SCHEMBL28854528 0.72 ERN1 (0.37) ALDH1A1TDP1HIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160264612-A1 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA UNIV COLUMBIA (US) 2016-09-15 US claimed
US-20130096015-A1 Massive Parallel Method For Decoding DNA And RNA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-04-18 US claimed
US-7345159-B2 Massive parallel method for decoding DNA and RNA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-03-18 US claimed
EP-1790736-A2 Massive parallel method for decoding DNA and RNA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2007-05-30 EP claimed
EP-1337541-B1 Massive parallel method for decoding DNA and RNA UNIV COLUMBIA (US) 2007-03-07 EP claimed
US-20040185466-A1 to detect single nucleotide polymorphisms, genetic mutation, gene expression, forensic identification, disease association, DNA/genomic sequencing and translation/transcription analysis; solid phase synthesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK. 2004-09-23 US claimed
US-6664079-B2 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2003-12-16 US claimed
US-20020102586-A1 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences NATIONAL SCIENCE FOUNDATION 2002-08-01 US claimed
US-11940413-B2 Methods and devices for sequencing nucleic acids in smaller batches IsoPlexis Corporation (US) 2024-03-26 US disclosed
US-20240076731-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES QIAGEN SCIENCES, LLC 2024-03-07 US disclosed
US-20240060128-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES QIAGEN WALTHAM, INC. 2024-02-22 US disclosed
US-20230407384-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES QIAGEN WALTHAM, INC. 2023-12-21 US disclosed
US-20210230686-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES IsoPlexis Corporation 2021-07-29 US disclosed
US-20210231609-A1 METHODS AND DEVICES FOR SEQUENCING NUCLEIC ACIDS IN SMALLER BATCHES IsoPlexis Corporation 2021-07-29 US disclosed
US-20040185466-A1 to detect single nucleotide polymorphisms, genetic mutation, gene expression, forensic identification, disease association, DNA/genomic sequencing and translation/transcription analysis; solid phase synthesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK. 2004-09-23 US disclosed
EP-1337541-A4 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA UNIV COLUMBIA (US) 2004-07-14 EP disclosed
US-6664079-B2 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2003-12-16 US disclosed
EP-1337541-A2 Massive parallel method for decoding DNA and RNA The Trustees of Columbia University in the City of New York (US) 2003-08-27 EP disclosed
US-20020102586-A1 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences NATIONAL SCIENCE FOUNDATION 2002-08-01 US disclosed
WO-2002029003-A2 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230686-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES NT5C2, NOP2, NT5C3B ALDH1A1 4837/4885TDP1 116/4885HIF1A 1141/4885
US-20160264612-A1 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA RNGTT, NSUN2, RNMT ALDH1A1 3815/4885TDP1 299/4885HIF1A 3580/4885
US-20240076731-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES NT5C2, NOP2, NT5C3B ALDH1A1 4837/4885TDP1 116/4885HIF1A 1141/4885
US-20230407384-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES NT5C2, NOP2, NT5C3B ALDH1A1 4837/4885TDP1 116/4885HIF1A 1141/4885
US-20240060128-A1 METHODS AND COMPOSITIONS FOR INCORPORATING NUCLEOTIDES NT5C2, NOP2, NT5C3B ALDH1A1 4837/4885TDP1 116/4885HIF1A 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.